Crosstalk between microbiota, pathogens and the innate immune responses

International Journal of Medical Microbiology

Volumn 306, Issue 5, 2016, Pages 257-265

  Günther, Claudia ^a   Josenhans, Christine ^b,c   Wehkamp, Jan ^d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c German Centre for Infection Research (DZIF)   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antimicrobial peptides; Barrier function; Cell death pathways; Innate immune responses; Microbiota; Pathogens

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

CELL DEATH; DYSBIOSIS; ENTERITIS; HOST CELL; HUMAN; INNATE IMMUNITY; INTESTINE INFECTION; MICROFLORA; NONHUMAN; PATHOGENESIS; SHORT SURVEY; ANIMAL; ECOSYSTEM; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL DEATH; DYSBIOSIS; ECOSYSTEM; HUMANS; IMMUNITY, INNATE; MICROBIOTA;

EID: 84961226971     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2016.03.003     Document Type: Short Survey

References (157)

1. Abt, M.C., Lewis, B.B., Caballero, S., Xiong, H., Carter, R.A., Susac, B., Ling, L., Leiner, I., Pamer, E.G., Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18:1 (2015), 27–37.
2. Ahern, P.P., Faith, J.J., Gordon, J.I., Mining the human gut microbiota for effector strains that shape the immune system. Immunity 40:6 (2014), 815–823.
3. Arnold, J.W., Niesel, D.W., Annable, C.R., Hess, C.B., Asuncion, M., Cho, Y.J., Peterson, J.W., Klimpel, G.R., Tumor necrosis factor-alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb. Pathog. 14:3 (1993), 217–227.
4. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., Kim, S., Fritz, J.V., Wilmes, P., Ueha, S., Matsushima, K., Ohno, H., Olle, B., Sakaguchi, S., Taniguchi, T., Morita, H., Hattori, M., Honda, K., Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500:7461 (2013), 232–236.
5. Balmer, M.L., Schurch, C.M., Saito, Y., Geuking, M.B., Li, H., Cuenca, M., Kovtonyuk, L.V., McCoy, K.D., Hapfelmeier, S., Ochsenbein, A.F., Manz, M.G., Slack, E., Macpherson, A.J., Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. J. Immunol. 193:10 (2014), 5273–5283.
6. Bartfeld, S., Bayram, T., van de Wetering, M., Huch, M., Begthel, H., Kujala, P., Vries, R., Peters, P.J., Clevers, H., In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 148:1 (2015), 126–136.
7. Barthel, M., Hapfelmeier, S., Quintanilla-Martinez, L., Kremer, M., Rohde, M., Hogardt, M., Pfeffer, K., Russmann, H., Hardt, W.D., Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:5 (2003), 2839–2858.
8. Becker, C., Neurath, M.F., Wirtz, S., The intestinal microbiota in inflammatory bowel disease. ILAR J. 56:2 (2015), 192–204.
9. Becker, C., Watson, A.J., Neurath, M.F., Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 144:2 (2013), 283–293.
10. Bereswill, S., Fischer, A., Plickert, R., Haag, L.M., Otto, B., Kuhl, A.A., Dasti, J.I., Zautner, A.E., Munoz, M., Loddenkemper, C., Gross, U., Gobel, U.B., Heimesaat, M.M., Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS ONE, 6(6), 2011, e20953.
11. Bevins, C.L., Innate immune functions of alpha-defensins in the small intestine. Dig. Dis. 31:3–4 (2013), 299–304.
12. Bischoff, S.C., Microbiota and aging. Curr. Opin. Clin. Nutr. Metab. Care 19:1 (2016), 26–30.
13. Boleij, A., Hechenbleikner, E.M., Goodwin, A.C., Badani, R., Stein, E.M., Lazarev, M.G., Ellis, B., Carroll, K.C., Albesiano, E., Wick, E.C., Platz, E.A., Pardoll, D.M., Sears, C.L., The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60:2 (2015), 208–215.
14. Bolton, D.J., Campylobacter virulence and survival factors. Food Microbiol. 48 (2015), 99–108.
15. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., Littmann, E., van den Brink, M.R., Jenq, R.R., Taur, Y., Sander, C., Cross, J.R., Toussaint, N.C., Xavier, J.B., Pamer, E.G., Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:7533 (2015), 205–208.
16. Bunker, J.J., Flynn, T.M., Koval, J.C., Shaw, D.G., Meisel, M., McDonald, B.D., Ishizuka, I.E., Dent, A.L., Wilson, P.C., Jabri, B., Antonopoulos, D.A., Bendelac, A., Innate and adaptive humoral responses coat distinct commensal bacteria with immunoglobulin A. Immunity 43:3 (2015), 541–553.
17. Burrows, M.P., Volchkov, P., Kobayashi, K.S., Chervonsky, A.V., Microbiota regulates type 1 diabetes through Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 112:32 (2015), 9973–9977.
18. Carneiro, L.A., Travassos, L.H., Soares, F., Tattoli, I., Magalhaes, J.G., Bozza, M.T., Plotkowski, M.C., Sansonetti, P.J., Molkentin, J.D., Philpott, D.J., Girardin, S.E., Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells. Cell Host Microbe 5:2 (2009), 123–136.
19. Castano-Rodriguez, N., Kaakoush, N.O., Lee, W.S., Mitchell, H.M., Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut, 2015 pii: gutjnl-2015-310545.
20. Castro, C.N., Freitag, J., Berod, L., Lochner, M., Sparwasser, T., Microbe-associated immunomodulatory metabolites: influence on T cell fate and function. Mol. Immunol. 68:2 Pt C (2015), 575–584.
21. Chassaing, B., Koren, O., Carvalho, F.A., Ley, R.E., Gewirtz, A.T., AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 63:7 (2014), 1069–1080.
22. Chassaing, B., Ley, R.E., Gewirtz, A.T., Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology, 147(6), 2014 1363.e17–1377.e17.
23. Cho, I., Yamanishi, S., Cox, L., Methe, B.A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., Li, H., Alekseyenko, A.V., Blaser, M.J., Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488 (2012), 621–626.
24. Chu, H., Pazgier, M., Jung, G., Nuccio, S.P., Castillo, P.A., de Jong, M.F., Winter, M.G., Winter, S.E., Wehkamp, J., Shen, B., Salzman, N.H., Underwood, M.A., Tsolis, R.M., Young, G.M., Lu, W., Lehrer, R.I., Baumler, A.J., Bevins, C.L., Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337:6093 (2012), 477–481.
25. Clevers, H.C., Bevins, C.L., Paneth cells: maestros of the small intestinal crypts. Annu. Rev. Physiol. 75 (2013), 289–311.
26. Cobo, E.R., Kissoon-Singh, V., Moreau, F., Chadee, K., Colonic MUC2 mucin regulates the expression and antimicrobial activity of beta-defensin 2. Muc. Immunol. 8 (2015), 1360–1372.
27. Collins, J., Auchtung, J.M., Schaefer, L., Eaton, K.A., Britton, R.A., Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome, 3, 2015, 35.
28. Courth, L.F., Ostaff, M.J., Mailander-Sanchez, D., Malek, N.P., Stange, E.F., Wehkamp, J., Crohn's disease-derived monocytes fail to induce Paneth cell defensins. Proc. Natl. Acad. Sci. U.S.A. 112:45 (2015), 14000–14005.
29. Dejea, C.M., Wick, E.C., Hechenbleikner, E.M., White, J.R., Mark Welch, J.L., Rossetti, B.J., Peterson, S.N., Snesrud, E.C., Borisy, G.G., Lazarev, M., Stein, E., Vadivelu, J., Roslani, A.C., Malik, A.A., Wanyiri, J.W., Goh, K.L., Thevambiga, I., Fu, K., Wan, F., Llosa, N., Housseau, F., Romans, K., Wu, X., McAllister, F.M., Wu, S., Vogelstein, B., Kinzler, K.W., Pardoll, D.M., Sears, C.L., Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 111:51 (2014), 18321–18326.
30. Dingemanse, C., Belzer, C., van Hijum, S.A., Gunthel, M., Salvatori, D., den Dunnen, J.T., Kuijper, E.J., Devilee, P., de Vos, W.M., van Ommen, G.B., Robanus-Maandag, E.C., Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis 36:11 (2015), 1388–1396.
31. Dupont, A., Heinbockel, L., Brandenburg, K., Hornef, M.W., Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa. Gut Microbes 5:6 (2014), 761–765.
32. Dupont, A., Kaconis, Y., Yang, I., Albers, T., Woltemate, S., Heinbockel, L., Andersson, M., Suerbaum, S., Brandenburg, K., Hornef, M.W., Intestinal mucus affinity and biological activity of an orally administered antibacterial and anti-inflammatory peptide. Gut 64:2 (2015), 222–232.
33. El Chamy, L., Matt, N., Ntwasa, M., Reichhart, J.M., The multilayered innate immune defense of the gut. Biomed. J. 38 (2015), 276–284.
34. Endt, K., Stecher, B., Chaffron, S., Slack, E., Tchitchek, N., Benecke, A., Van Maele, L., Sirard, J.C., Mueller, A.J., Heikenwalder, M., Macpherson, A.J., Strugnell, R., von Mering, C., Hardt, W.D., The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog., 6(9), 2010, e1001097.
35. Ericsson, A.C., Akter, S., Hanson, M.M., Busi, S.B., Parker, T.W., Schehr, R.J., Hankins, M.A., Ahner, C.E., Davis, J.W., Franklin, C.L., Amos-Landgraf, J.M., Bryda, E.C., Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota. Oncotarget 6:32 (2015), 33689–33704.
36. Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R.G., Cochez, P., Pierard, F., Castel, J., Bindels, L.B., Plovier, H., Robine, S., Muccioli, G.G., Renauld, J.C., Dumoutier, L., Delzenne, N.M., Luquet, S., Backhed, F., Cani, P.D., Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun., 5, 2014, 5648.
37. Faber, E., Gripp, E., Maurischat, S., Kaspers, B., Tedin, K., Menz, S., Zuraw, A., Kershaw, O., Yang, I., Rautenschlein, S., Josenhans, C., Novel immunomodulatory Flagellin-like protein FlaC in Campylobacter jejuni and other campylobacterales. mSphere, 1(1), 2015, e00028 [Epub Nov 2nd 2015].
38. Fischer, W., Prassl, S., Haas, R., Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori. Curr. Top. Microbiol. Immunol. 337 (2009), 129–171.
39. Foersch, S., Neurath, M.F., Colitis-associated neoplasia: molecular basis and clinical translation. Cell. Mol. Life Sci. 71:18 (2014), 3523–3535.
40. Fonseca, D.M., Hand, T.W., Han, S.J., Gerner, M.Y., Glatman Zaretsky, A., Byrd, A.L., Harrison, O.J., Ortiz, A.M., Quinones, M., Trinchieri, G., Brenchley, J.M., Brodsky, I.E., Germain, R.N., Randolph, G.J., Belkaid, Y., Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 163:2 (2015), 354–366.
41. Foster, D.M., Stauffer, S.H., Stone, M.R., Gookin, J.L., Proteasome inhibition of pathologic shedding of enterocytes to defend barrier function requires X-linked inhibitor of apoptosis protein and nuclear factor kappaB. Gastroenterology, 143(1), 2012 133.e4–144.e4.
42. Frick, J.S., Schenk, K., Quitadamo, M., Kahl, F., Koberle, M., Bohn, E., Aepfelbacher, M., Autenrieth, I.B., Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm. Bowel Dis. 13:1 (2007), 83–90.
43. Fulde, M., Hornef, M.W., Maturation of the enteric mucosal innate immune system during the postnatal period. Immunol. Rev. 260:1 (2014), 21–34.
44. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:7480 (2013), 446–450.
45. Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., Eberl, G., Snel, J., Kelly, D., Cerf-Bensussan, N., The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:4 (2009), 677–689.
46. Galipeau, H.J., McCarville, J.L., Huebener, S., Litwin, O., Meisel, M., Jabri, B., Sanz, Y., Murray, J.A., Jordana, M., Alaedini, A., Chirdo, F.G., Verdu, E.F., Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am. J. Pathol. 185:11 (2015), 2969–2982.
47. Gao, Z., Guo, B., Gao, R., Zhu, Q., Qin, H., Microbiota disbiosis is associated with colorectal cancer. Front. Microbiol., 6, 2015, 20.
48. Gebhart, D., Lok, S., Clare, S., Tomas, M., Stares, M., Scholl, D., Donskey, C.J., Lawley, T.D., Govoni, G.R., A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity. mBio, 6(2), 2015, e02368.
49. Geis, A.L., Fan, H., Wu, X., Wu, S., Huso, D.L., Wolfe, J.L., Sears, C.L., Pardoll, D.M., Housseau, F., Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis. Cancer Discovery 5:10 (2015), 1098–1109.
50. Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J.T., Spector, T.D., Clark, A.G., Ley, R.E., Human genetics shape the gut microbiome. Cell 159:4 (2014), 789–799.
51. Gronbach, K., Flade, I., Holst, O., Lindner, B., Ruscheweyh, H.J., Wittmann, A., Menz, S., Schwiertz, A., Adam, P., Stecher, B., Josenhans, C., Suerbaum, S., Gruber, A.D., Kulik, A., Huson, D., Autenrieth, I.B., Frick, J.S., Endotoxicity of lipopolysaccharide as a determinant of T-cell-mediated colitis induction in mice. Gastroenterology 146:3 (2014), 765–775.
52. Gunther, C., Buchen, B., He, G.W., Hornef, M., Torow, N., Neumann, H., Wittkopf, N., Martini, E., Basic, M., Bleich, A., Watson, A.J., Neurath, M.F., Becker, C., Caspase-8 controls the gut response to microbial challenges by Tnf-alpha-dependent and independent pathways. Gut 64:4 (2015), 601–610.
53. Gunther, C., Buchen, B., Neurath, M.F., Becker, C., Regulation and pathophysiological role of epithelial turnover in the gut. Semin. Cell. Dev. Biol. 35 (2014), 40–50.
54. Gunther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M.J., Hedrick, S.M., Tenzer, S., Neurath, M.F., Becker, C., Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477:7364 (2011), 335–339.
55. Gunther, C., Neumann, H., Neurath, M.F., Becker, C., Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 62:7 (2013), 1062–1071.
56. Guo, X., Liang, Y., Zhang, Y., Lasorella, A., Kee, B.L., Fu, Y.X., Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity 42:4 (2015), 731–743.
57. Han, D., Walsh, M.C., Cejas, P.J., Dang, N.N., Kim, Y.F., Kim, J., Charrier-Hisamuddin, L., Chau, L., Zhang, Q., Bittinger, K., Bushman, F.D., Turka, L.A., Shen, H., Reizis, B., Defranco, A.L., Wu, G.D., Choi, Y., Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. Immunity 38:6 (2013), 1211–1222.
58. Harder, J., Bartels, J., Christophers, E., Schroder, J.M., Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:8 (2001), 5707–5713.
59. Hold, G.L., Garrett, W.S., Gut microbiota. Microbiota organization—a key to understanding CRC development. Nat. Rev. Gastroenterol. Hepatol. 12:3 (2015), 128–129.
60. Hu, S., Peng, L., Kwak, Y.T., Tekippe, E.M., Pasare, C., Malter, J.S., Hooper, L.V., Zaki, M.H., The DNA sensor AIM2 maintains intestinal homeostasis via regulation of epithelial antimicrobial host defense. Cell Rep. 13:9 (2015), 1922–1936.
61. Hsiao, A., Ahmed, A.M., Subramanian, S., Griffin, N.W., Drewry, L.L., Petri, W.A. Jr., Haque, R., Ahmed, T., Gordon, J.I., Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 515:7527 (2014), 423–426.
62. Irrazabal, T., Belcheva, A., Girardin, S.E., Martin, A., Philpott, D.J., The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell 54:2 (2014), 309–320.
63. Jakobsson, H.E., Rodriguez-Pineiro, A.M., Schutte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Backhed, F., Hansson, G.C., Johansson, M.E., The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 16:2 (2015), 164–177.
64. Jorgensen, I., Miao, E.A., Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265:1 (2015), 130–142.
65. Kampmann, C., Dicksved, J., Engstrand, L., Rautelin, H., Composition of human faecal microbiota in resistance to Campylobacter infection. Clin. Microbiol. Infect. 22:1 (2016), 61.e1–61.e8.
66. Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., Tameda, M., Shiraki, K., Ito, M., Takei, Y., Takase, K., Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: terminal restriction fragment length polymorphism and next-generation sequencing analyses. Oncol. Rep. 35:1 (2016), 325–333.
67. Kato, L.M., Kawamoto, S., Maruya, M., Fagarasan, S., The role of the adaptive immune system in regulation of gut microbiota. Immunol. Rev. 260:1 (2014), 67–75.
68. Kim, M., Ashida, H., Ogawa, M., Yoshikawa, Y., Mimuro, H., Sasakawa, C., Bacterial interactions with the host epithelium. Cell Host Microbe 8:1 (2010), 20–35.
69. Knights, D., Silverberg, M.S., Weersma, R.K., Gevers, D., Dijkstra, G., Huang, H., Tyler, A.D., van Sommeren, S., Imhann, F., Stempak, J.M., Huang, H., Vangay, P., Al-Ghalith, G.A., Russell, C., Sauk, J., Knight, J., Daly, M.J., Huttenhower, C., Xavier, R.J., Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med., 6(12), 2014, 107.
70. Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., Angenent, L.T., Ley, R.E., Succession of microbial consortia in the developing infant gut microbiome. Proc. Nat. Acad. Sci. U.S.A. 108:Suppl 1 (2011), 4578–4585.
71. Kostic, A.D., Chun, E., Meyerson, M., Garrett, W.S., Microbes and inflammation in colorectal cancer. Cancer Immunol. Res. 1:3 (2013), 150–157.
72. Kreuz, S., Siegmund, D., Scheurich, P., Wajant, H., NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21:12 (2001), 3964–3973.
73. Kubinak, J.L., Petersen, C., Stephens, W.Z., Soto, R., Bake, E., O'Connell, R.M., Round, J.L., MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17:2 (2015), 153–163.
74. Kubinak, J.L., Round, J.L., Toll-like receptors promote mutually beneficial commensal-host interactions. PLoS Pathog., 8(7), 2012, e1002785.
75. Lakshminarayanan, B., Stanton, C., O'Toole, P.W., Ross, R.P., Compositional dynamics of the human intestinal microbiota with aging: implications for health. J. Nutr. Health Aging 18:9 (2014), 773–786.
76. Lawrence, T., The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspect. Biol., 1(6), 2009, a001651.
77. Lecuyer, E., Rakotobe, S., Lengline-Garnier, H., Lebreton, C., Picard, M., Juste, C., Fritzen, R., Eberl, G., McCoy, K.D., Macpherson, A.J., Reynaud, C.A., Cerf-Bensussan, N., Gaboriau-Routhiau, V., Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses. Immunity 40:4 (2014), 608–620.
78. Lichtman, J.S., Alsentzer, E., Jaffe, M., Sprockett, D., Masutani, E., Ikwa, E., Fragiadakis, G.K., Clifford, D., Huang, B.E., Sonnenburg, J.L., Huang, K.C., Elias, J.E., The effect of microbial colonization on the host proteome varies by gastrointestinal location. ISME J., 2015, 10.1038/ismej.2015.187.
79. Lindner, C., Thomsen, I., Wahl, B., Ugur, M., Sethi, M.K., Friedrichsen, M., Smoczek, A., Ott, S., Baumann, U., Suerbaum, S., Schreiber, S., Bleich, A., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Hazanov, H., Mehr, R., Boysen, P., Rosenstiel, P., Pabst, O., Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota. Nat. Immunol. 16:8 (2015), 880–888.
80. Lindner, C., Wahl, B., Fohse, L., Suerbaum, S., Macpherson, A.J., Prinz, I., Pabst, O., Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine. J. Exp. Med. 209:2 (2012), 365–377.
81. Liu, Y.W., Denkmann, K., Kosciow, K., Dahl, C., Kelly, D.J., Tetrathionate stimulated growth of Campylobacter jejuni identifies a new type of bi-functional tetrathionate reductase (TsdA) that is widely distributed in bacteria. Mol. Microbiol. 88:1 (2013), 173–188.
82. Lopez-Posadas, R., Becker, C., Gunther, C., Tenzer, S., Amann, K., Billmeier, U., Atreya, R., Fiorino, G., Vetrano, S., Danese, S., Ekici, A.B., Wirtz, S., Thonn, V., Watson, A.J., Brakebusch, C., Bergo, M., Neurath, M.F., Atreya, I., Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation. J. Clin. Invest. 126:2 (2016), 611–626.
83. Lotz, M., Gutle, D., Walther, S., Menard, S., Bogdan, C., Hornef, M.W., Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203:4 (2006), 973–984.
84. Louis, P., Hold, G.L., Flint, H.J., The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12:10 (2014), 661–672.
85. Malireddi, R.K., Kanneganti, T.D., Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection. Front. Cell. Infect. Microbiol., 3, 2013, 77.
86. Martz, S.L., McDonald, J.A., Sun, J., Zhang, Y.G., Gloor, G.B., Noordhof, C., He, S.M., Gerbaba, T.K., Blennerhassett, M., Hurlbut, D.J., Allen-Vercoe, E., Claud, E.C., Petrof, E.O., Administration of defined microbiota is protective in a murine Salmonella infection model. Sci. Rep., 5, 2015, 16094.
87. McAllister, C.S., Lakhdari, O., Pineton de Chambrun, G., Gareau, M.G., Broquet, A., Lee, G.H., Shenouda, S., Eckmann, L., Kagnoff, M.F., TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo. J. Immunol. 190:1 (2013), 418–427.
88. McCracken, K.W., Catá, E.M., Crawford, C.M., Sinagoga, K.L., Schumacher, M., Rockich, B.E., Tsai, Y.H., Mayhew, C.N., Spence, J.R., Zavros, Y., Wells, J.M., Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516:7531 (2014), 400–404.
89. Monaghan, T.M., Cockayne, A., Mahida, Y.R., Pathogenesis of Clostridium difficile infection and its potential role in inflammatory bowel disease. Inflamm. Bowel Dis. 21:8 (2015), 1957–1966.
90. Nell, S., Suerbaum, S., Josenhans, C., The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat. Rev. Microbiol. 8:8 (2010), 564–577.
91. Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., Gumucio, D., Neurath, M.F., Pasparakis, M., Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:7135 (2007), 557–561.
92. Nobel, Y.R., Cox, L.M., Kirigin, F.F., Bokulich, N.A., Yamanishi, S., Teitler, I., Chung, J., Sohn, J., Barber, C.M., Goldfarb, D.S., Raju, K., Abubucker, S., Zhou, Y., Ruiz, V.E., Li, H., Mitreva, M., Alekseyenko, A.V., Weinstock, G.M., Sodergren, E., Blaser, M.J., Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat. Commun., 6, 2015, 7486.
93. O'Loughlin, J.L., Samuelson, D.R., Braundmeier-Fleming, A.G., White, B.A., Haldorson, G.J., Stone, J.B., Lessmann, J.J., Eucker, T.P., Konkel, M.E., The intestinal microbiota influences Campylobacter jejuni colonization and extraintestinal dissemination in mice. Appl. Environ. Microbiol. 81:14 (2015), 4642–4650.
94. Ocvirk, S., Sava, I.G., Lengfelder, I., Lagkouvardos, I., Steck, N., Roh, J.H., Tchaptchet, S., Bao, Y., Hansen, J.J., Huebner, J., Carroll, I.M., Murray, B.E., Sartor, R.B., Haller, D., Surface-associated lipoproteins link Enterococcus faecalis virulence to colitogenic activity in IL-10-deficient mice independent of their expression levels. PLoS Pathog., 11(6), 2015, e1004911.
95. Ohnmacht, C., Park, J.H., Cording, S., Wing, J.B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., Fedoseeva, M., Busslinger, M., Cerf-Bensussan, N., Boneca, I.G., Voehringer, D., Hase, K., Honda, K., Sakaguchi, S., Eberl, G., MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 349:6251 (2015), 989–993.
96. Ostaff, M.J., Stange, E.F., Wehkamp, J., Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol. Med. 5:10 (2013), 1465–1483.
97. Paesold, G., Guiney, D.G., Eckmann, L., Kagnoff, M.F., Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells. Cell. Microbiol. 4:11 (2002), 771–781.
98. Peterson, C.T., Sharma, V., Elmen, L., Peterson, S.N., Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin. Exp. Immunol. 179:3 (2015), 363–377.
99. Pott, J., Mahlakoiv, T., Mordstein, M., Duerr, C.U., Michiels, T., Stockinger, S., Staeheli, P., Hornef, M.W., IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U.S.A. 108:19 (2011), 7944–7949.
100. Quevrain, E., Maubert, M.A., Michon, C., Chain, F., Marquant, R., Tailhades, J., Miquel, S., Carlier, L., Bermudez-Humaran, L.G., Pigneur, B., Lequin, O., Kharrat, P., Thomas, G., Rainteau, D., Aubry, C., Breyner, N., Afonso, C., Lavielle, S., Grill, J.P., Chassaing, G., Chatel, J.M., Trugnan, G., Xavier, R., Langella, P., Sokol, H., Seksik, P., Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65:3 (2016), 415–425.
101. Rankin, L.C., Girard-Madoux, M.J., Seillet, C., Mielke, L.A., Kerdiles, Y., Fenis, A., Wieduwild, E., Putoczki, T., Mondot, S., Lantz, O., Demon, D., Papenfuss, A.T., Smyth, G.K., Lamkanfi, M., Carotta, S., Renauld, J.C., Shi, W., Carpentier, S., Soos, T., Arendt, C., Ugolini, S., Huntington, N.D., Belz, G.T., Vivier, E., Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat. Immunol. 17:2 (2016), 179–186.
102. Rescigno, M., The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 32:6 (2011), 256–264.
103. Robinson, N., McComb, S., Mulligan, R., Dudani, R., Krishnan, L., Sad, S., Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13:10 (2012), 954–962.
104. Rolig, A.S., Parthasarathy, R., Burns, A.R., Bohannan, B.J., Guillemin, K., Individual members of the microbiota disproportionately modulate host innate immune responses. Cell Host Microbe 18:5 (2015), 613–620.
105. Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., Mazmanian, S.K., The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:6032 (2011), 974–977.
106. Salzman, N.H., Paneth cell defensins and the regulation of the microbiome: detente at mucosal surfaces. Gut Microbes 1:6 (2010), 401–406.
107. Salzman, N.H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjoberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D., Stoel, M., Zhou, Y., Sodergren, E., Weinstock, G.M., Bevins, C.L., Williams, C.B., Bos, N.A., Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11:1 (2010), 76–83.
108. Sassone-Corsi, M., Raffatellu, M., No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens. J. Immunol. 194:9 (2015), 4081–4087.
109. Schaubeck, M., Clavel, T., Calasan, J., Lagkouvardos, I., Haange, S.B., Jehmlich, N., Basic, M., Dupont, A., Hornef, M., Bergen, M., Bleich, A., Haller, D., Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut 65:2 (2016), 225–237.
110. Schauser, K., Olsen, J.E., Larsson, L.I., Salmonella typhimurium infection in the porcine intestine: evidence for caspase-3-dependent and -independent programmed cell death. Histochem. Cell Biol. 123:1 (2005), 43–50.
111. Schlaermann, P., Toelle, B., Berger, H., Schmidt, S.C., Glanemann, M., Ordemann, J., Bartfeld, S., Mollenkopf, H.J., Meyer, T.F., A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro. Gut 65:2 (2016), 202–213.
112. Schroeder, B.O., Ehmann, D., Precht, J.C., Castillo, P.A., Kuchler, R., Berger, J., Schaller, M., Stange, E.F., Wehkamp, J., Paneth cell alpha-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol. 8:3 (2015), 661–671.
113. Schroeder, B.O., Wu, Z., Nuding, S., Groscurth, S., Marcinowski, M., Beisner, J., Buchner, J., Schaller, M., Stange, E.F., Wehkamp, J., Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 469:7330 (2011), 419–423.
114. Schubert, A.M., Sinani, H., Schloss, P.D., Antibiotic-induced alterations of the murine gut microbiota and subsequent effects on colonization resistance against Clostridium difficile. mBio, 6(4), 2015, e00974.
115. Sears, C.L., Garrett, W.S., Microbes, microbiota, and colon cancer. Cell Host Microbe 15:3 (2014), 317–328.
116. Sellin, M.E., Maslowski, K.M., Maloy, K.J., Hardt, W.D., Inflammasomes of the intestinal epithelium. Trends Immunol. 36:8 (2015), 442–450.
117. Selsted, M.E., Ouellette, A.J., Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:6 (2005), 551–557.
118. Sham, H.P., Yu, E.Y., Gulen, M.F., Bhinder, G., Stahl, M., Chan, J.M., Brewster, L., Morampudi, V., Gibson, D.L., Hughes, M.R., McNagny, K.M., Li, X., Vallance, B.A., SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog., 9(8), 2013, e1003539.
119. Sheflin, A.M., Whitney, A.K., Weir, T.L., Cancer-promoting effects of microbial dysbiosis. Curr. Oncol. Rep., 16(10), 2014, 406.
120. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:6145 (2013), 569–573.
121. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H.M., Dore, J., Marteau, P., Seksik, P., Langella, P., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105:43 (2008), 16731–16736.
122. Specian, R.D., Oliver, M.G., Functional biology of intestinal goblet cells. Am. J. Physiol. 260:2 Pt 1 (1991), C183–C193.
123. Stahl, M., Ries, J., Vermeulen, J., Yang, H., Sham, H.P., Crowley, S.M., Badayeva, Y., Turvey, S.E., Gaynor, E.C., Li, X., Vallance, B.A., A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection. PLoS Pathog., 10(7), 2014, e1004264.
124. Stecher, B., The roles of inflammation. Nutrient availability and the commensal microbiota in enteric pathogen infection. Microbiol. Spectr., 3(3), 2015 MBP-0008-2014.
125. Stockinger, S., Duerr, C.U., Fulde, M., Dolowschiak, T., Pott, J., Yang, I., Eibach, D., Backhed, F., Akira, S., Suerbaum, S., Brugman, M., Hornef, M.W., TRIF signaling drives homeostatic intestinal epithelial antimicrobial peptide expression. J. Immunol. 193:8 (2014), 4223–4234.
126. Stowell, S.R., Arthur, C.M., McBride, R., Berger, O., Razi, N., Heimburg-Molinaro, J., Rodrigues, L.C., Gourdine, J.P., Noll, A.J., von Gunten, S., Smith, D.F., Knirel, Y.A., Paulson, J.C., Cummings, R.D., Microbial glycan microarrays define key features of host-microbial interactions. Nat. Chem. Biol. 10:6 (2014), 470–476.
127. Swiatczak, B., Cohen, I.R., Gut feelings of safety: tolerance to the microbiota mediated by innate immune receptors. Microbiol. Immunol. 59:10 (2015), 573–585.
128. Takahashi, N., Vereecke, L., Bertrand, M.J., Duprez, L., Berger, S.B., Divert, T., Goncalves, A., Sze, M., Gilbert, B., Kourula, S., Goossens, V., Lefebvre, S., Gunther, C., Becker, C., Bertin, J., Gough, P.J., Declercq, W., van Loo, G., Vandenabeele, P., RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513:7516 (2014), 95–99.
129. Tlaskalova-Hogenova, H., Vannucci, L., Klimesova, K., Stepankova, R., Krizan, J., Kverka, M., Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models. Cancer J. 20:3 (2014), 217–224.
130. Underwood, M.A., Arriola, J., Gerber, C.W., Kaveti, A., Kalanetra, K.M., Kananurak, A., Bevins, C.L., Mills, D.A., Dvorak, B., Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr. Res. 76:4 (2014), 326–333.
131. Uronis, J.M., Muhlbauer, M., Herfarth, H.H., Rubinas, T.C., Jones, G.S., Jobin, C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE, 4(6), 2009, e6026.
132. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., Kroemer, G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11:10 (2010), 700–714.
133. van de Wetering, M., Francies, H.E., Francis, J.M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., McLaren-Douglas, A., Blokker, J., Jaksani, S.S., Bartfeld, S.S., Volckman, R., van Sluis, P., Li, V.S., Seepo, S., Sekhar Pedamallu, C., Cibulskis, K., Carter, S.L., McKenna, A., Lawrence, M.S., Lichtenstein, L., Stewart, C., Koster, J., Versteeg, R., van Oudenaarden, A., Saez-Rodriguez, J., Vries, R.G., Getz, G., Wessels, L., Stratton, M.R., McDermott, U., Meyerson, M., Garnett, M.J., Clevers, H., Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:4 (2015), 933–945.
134. Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., Poirier-Colame, V., Roux, A., Becharef, S., Formenti, S., Golden, E., Cording, S., Eberl, G., Schlitzer, A., Ginhoux, F., Mani, S., Yamazaki, T., Jacquelot, N., Enot, D.P., Berard, M., Nigou, J., Opolon, P., Eggermont, A., Woerther, P.L., Chachaty, E., Chaput, N., Robert, C., Mateus, C., Kroemer, G., Raoult, D., Boneca, I.G., Carbonnel, F., Chamaillard, M., Zitvogel, L., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:6264 (2015), 1079–1084.
135. Vlantis, K., Polykratis, A., Welz, P.S., van Loo, G., Pasparakis, M., Wullaert, A., TLR-independent anti-inflammatory function of intestinal epithelial TRAF6 signalling prevents DSS-induced colitis in mice. Gut, 2015 pii: gutjnl-2014-308323.
136. von Schillde, M.A., Hormannsperger, G., Weiher, M., Alpert, C.A., Hahne, H., Bauerl, C., van Huynegem, K., Steidler, L., Hrncir, T., Perez-Martinez, G., Kuster, B., Haller, D., Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11:4 (2012), 387–396.
137. Walsh, C.J., Guinane, C.M., O'Toole, P.W., Cotter, P.D., Beneficial modulation of the gut microbiota. FEBS Lett. 588:22 (2014), 4120–4130.
138. Wang, H., Kim, J.J., Denou, E., Gallagher, A., Thornton, D.J., Shajib, M.S., Xia, L., Schertzer, J.D., Grencis, R.K., Philpott, D.J., Khan, W.I., New role of nod proteins in regulation of intestinal goblet cell response in the context of innate host defense in an enteric parasite infection. Infect. Immun. 84:1 (2015), 275–285.
139. Wang, P., Zhu, S., Yang, L., Cui, S., Pan, W., Jackson, R., Zheng, Y., Rongvaux, A., Sun, Q., Yang, G., Gao, S., Lin, R., You, F., Flavell, R., Fikrig, E., Nlrp6 regulates intestinal antiviral innate immunity. Science 350:6262 (2015), 826–830.
140. Wehkamp, J., Salzman, N.H., Porter, E., Nuding, S., Weichenthal, M., Petras, R.E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., Feathers, R.W., Chu, H., Lima, H. Jr., Fellermann, K., Ganz, T., Stange, E.F., Bevins, C.L., Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U.S.A. 102:50 (2005), 18129–18134.
141. Wehkamp, J., Schmid, M., Fellermann, K., Stange, E.F., Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J. Leukocyte Biol. 77:4 (2005), 460–465.
142. Wehkamp, J., Stange, E.F., Paneth's disease. J. Crohns Colitis 4:5 (2010), 523–531.
143. Welz, P.S., Wullaert, A., Vlantis, K., Kondylis, V., Fernandez-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., Pasparakis, M., FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477:7364 (2011), 330–334.
144. Winter, S.E., Thiennimitr, P., Winter, M.G., Butler, B.P., Huseby, D.L., Crawford, R.W., Russell, J.M., Bevins, C.L., Adams, L.G., Tsolis, R.M., Roth, J.R., Bäumler, A.J., Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467:7314 (2010), 426–429.
145. Winter, S.E., Baumler, A.J., Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 5:1 (2014), 71–73.
146. Wittkopf, N., Gunther, C., Martini, E., He, G., Amann, K., He, Y.W., Schuchmann, M., Neurath, M.F., Becker, C., Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8. Gastroenterology 145:6 (2013), 1369–1379.
147. Wittkopf, N., Pickert, G., Billmeier, U., Mahapatro, M., Wirtz, S., Martini, E., Leppkes, M., Neurath, M.F., Becker, C., Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection. PLoS ONE, 10(3), 2015, e0118401.
148. Wittmann, A., Autenrieth, I.B., Frick, J.S., Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection. PLoS ONE, 8(8), 2013, e71338.
149. Wittmann, A., Bron, P.A., van, S. II, Kleerebezem, M., Adam, P., Gronbach, K., Menz, S., Flade, I., Bender, A., Schafer, A., Korkmaz, A.G., Parusel, R., Autenrieth, I.B., Frick, J.S., TLR signaling-induced CD103-expressing cells protect against intestinal inflammation. Inflamm. Bowel Dis. 21:3 (2015), 507–519.
150. Wlodarska, M., Kostic, A.D., Xavier, R.J., An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17:5 (2015), 577–591.
151. Wrzosek, L., Miquel, S., Noordine, M.L., Bouet, S., Joncquel Chevalier-Curt, M., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., Langella, P., Thomas, M., Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol., 11, 2013, 61.
152. Wullaert, A., Bonnet, M.C., Pasparakis, M., NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res. 21:1 (2011), 146–158.
153. Yang, I., Woltemate, S., Piazuelo, M.B., Bravo, L.E., Yepez, M.C., Romero-Gallo, J., Delgado, A.G., Wilson, K.T., Peek, R.M., Correa, P., Josenhans, C., Fox, J.G., Suerbaum, S., Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci. Rep., 6, 2016, 18594.
154. Zackular, J.P., Baxter, N.T., Iverson, K.D., Sadler, W.D., Petrosino, J.F., Chen, G.Y., Schloss, P.D., The gut microbiome modulates colon tumorigenesis. mBio, 4(6), 2013 e00001-15.
155. Zackular, J.P., Baxter, N.T., Chen, G.Y., Schloss, P.D., Manipulation of the gut microbiota reveals role in colon tumorigenesis. mSphere, 1(1), 2015, 00001-15.
156. Zeissig, S., Bojarski, C., Buergel, N., Mankertz, J., Zeitz, M., Fromm, M., Schulzke, J.D., Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 53:9 (2004), 1295–1302.
157. Zhang, Y.G., Wu, S., Xia, Y., Sun, J., Salmonella-infected crypt-derived intestinal organoid culture system for host-bacterial interactions. Physiol. Rep., 2(9), 2014, e12147.